Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Lupin gets USFDA nod to market fungal infection cream

      Lupin gets USFDA nod to market fungal infection cream

      Ruby Khatun Khatun7 Jun 2018 10:30 AM IST
      New Delhi: Drug firm Lupin said it has received final approval from the US health regulator to market its Nystatin and Triamcinolone Acetonide cream...
      USFDA issues no observation on Zydus Ahmedabad facility

      USFDA issues no observation on Zydus Ahmedabad facility

      Ruby Khatun Khatun7 Jun 2018 10:15 AM IST
      New Delhi: Zydus Cadila’s wholly-owned subsidiary Alidac Pharmaceuticals has not received any observation from the US health regulator after the...
      MSME, AYUSH ministries to develop traditional medicine enterprises

      MSME, AYUSH ministries to develop traditional medicine enterprises

      Ruby Khatun Khatun7 Jun 2018 10:00 AM IST
      New Delhi: Ministries of MSME and AYUSH joined hands for developing enterprises in the traditional medicine sector."The memorandum of understanding...
      Novartis, aiming to go toe-to-toe with Humira, wins EU panel nod

      Novartis, aiming to go toe-to-toe with Humira, wins EU panel nod

      Ruby Khatun Khatun7 Jun 2018 9:45 AM IST
      ZURICH: Novartis’s generics unit won a European panel’s recommendation for its biosimilar version of AbbVie’s Humira as the Swiss drugmaker aims to...
      Imerys unit settles talc claims for at least 5 million dollar : Bloomberg

      Imerys unit settles talc claims for at least 5 million dollar : Bloomberg

      Ruby Khatun Khatun7 Jun 2018 9:30 AM IST
      A unit of French minerals company Imerys SA settled claims by 22 women related to talc supplied to Johnson and Johnson for making baby powder for at...
      Mamata slams Centre for rise in price of anti-rabies vaccine

      Mamata slams Centre for rise in price of anti-rabies vaccine

      Ruby Khatun Khatun6 Jun 2018 1:56 PM IST
      Kolkata: West Bengal Chief Minister Mamata Banerjee slammed the Centre for the rise in the price of anti-rabies vaccine, making it scarce for the...
      Lupin launches generic drug to control postpartum hemorrhage in US

      Lupin launches generic drug to control postpartum hemorrhage in US

      Ruby Khatun Khatun6 Jun 2018 10:45 AM IST
      New Delhi: Drug maker Lupin launched Methylergonovine Maleate tablets, used for prevention and control of postpartum hemorrhage, in the American...
      USFDA approves Mylan, Biocon

      USFDA approves Mylan, Biocon's Fulphila, the first biosimilar to Neulasta

      Ruby Khatun Khatun6 Jun 2018 10:30 AM IST
      HERTFORDSHIRE/PITTSBURGH and BENGALURU: Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Mylan's...
      Unichem Labs Ghaziabad unit gets EIR from USFDA

      Unichem Lab's Ghaziabad unit gets EIR from USFDA

      Ruby Khatun Khatun6 Jun 2018 10:15 AM IST
      New Delhi: Drug firm Unichem Laboratories said its facility at Ghaziabad has received establishment inspection report (EIR) from the US health...
      Senior Marketing Director-Biocon, Vasudev Tribhuvan, joins Wellthy Therapeutics

      Senior Marketing Director-Biocon, Vasudev Tribhuvan, joins Wellthy Therapeutics

      Ruby Khatun Khatun6 Jun 2018 10:00 AM IST
      Mumbai: Wellthy Therapeutics (Wellthy) announced the appointment of Vasudev V. Tribhuvan as Vice President, Partnerships & Alliances effective May...
      FDA chief outlines new ways to speed cancer drug approvals

      FDA chief outlines new ways to speed cancer drug approvals

      Ruby Khatun Khatun6 Jun 2018 9:45 AM IST
      CHICAGO: The U.S. Food and Drug Administration is taking steps to streamline the approval process for cancer drugs, reviewing clinical trial data up...
      Novartis readies anti-sexism message for migraine drug

      Novartis readies anti-sexism message for migraine drug

      Ruby Khatun Khatun6 Jun 2018 9:30 AM IST
      ZURICH: With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to counteract sexism that it...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok